Photo of Ingrid Scott
Contact Expert

View Scopus Profile

Ingrid Scott, MD, MPH

    • 15006 Citations
    • 67 h-Index
    1992 …2022
    If you made any changes in Pure, your changes will be visible here soon.

    Fingerprint Dive into the research topics where Ingrid Scott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 10 Similar Profiles
    Visual Acuity Medicine & Life Sciences
    Endophthalmitis Medicine & Life Sciences
    Macular Edema Medicine & Life Sciences
    Vitrectomy Medicine & Life Sciences
    Retinal Vein Occlusion Medicine & Life Sciences
    Intravitreal Injections Medicine & Life Sciences
    Retinal Detachment Medicine & Life Sciences
    Diabetic Retinopathy Medicine & Life Sciences

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects 2002 2022

    SCORE2 Comparative Trial (SCT)

    Scott, I.

    National Institutes of Health

    9/30/13 → 3/31/22

    Project: Research project

    Retinal Vein
    Retinal Vein Occlusion
    Optical Coherence Tomography
    Visual Acuity
    Clinical Protocols

    Eye Disease in Cuban-American and Puerto Rican Adults

    Scott, I.

    National Institutes of Health

    9/30/02 → 8/31/04

    Project: Research project

    Eye Diseases
    Hispanic Americans
    Vision Disorders
    Interviews
    Puerto Rico

    Research Output 1992 2019

    Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial

    Rodrigues, M. W., Cardillo, J. A., Messias, A., Siqueira, R. C., Scott, I. U. & Jorge, R., Jan 1 2019, (Accepted/In press) In : Graefe's Archive for Clinical and Experimental Ophthalmology.

    Research output: Contribution to journal › Article

    Triamcinolone
    Macular Edema
    Triamcinolone Acetonide
    Randomized Controlled Trials
    Visual Acuity
    1 Citation (Scopus)

    Intraoperative aberrometry versus preoperative biometry for intraocular lens power selection in short eyes

    Sudhakar, S., Hill, D. C., King, T. S., Scott, I. U., Mishra, G., Ernst, B. B. & Pantanelli, S. M., Jun 2019, In : Journal of Cataract and Refractive Surgery. 45, 6, p. 719-724 6 p.

    Research output: Contribution to journal › Article

    Aberrometry
    Biometry
    Intraocular Lenses
    Confidence Intervals
    Eye Axial Length
    1 Citation (Scopus)

    LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS

    SCORE2 Investigator Group, Sep 1 2019, In : Retina (Philadelphia, Pa.). 39, 9, p. 1802-1809 8 p.

    Research output: Contribution to journal › Article

    Infertility
    Vascular Endothelial Growth Factor A
    Glass
    Syringes
    Intravitreal Injections

    Month 12 Outcomes after Treatment Change at Month 6 among Poor Responders to Aflibercept or Bevacizumab in Eyes with Macular Edema Secondary to Central or Hemiretinal Vein Occlusion: A Secondary Analysis of the SCORE2 Study

    Ip, M. S., Oden, N. L., Scott, I. U., Vanveldhuisen, P. C., Blodi, B. A., Ghuman, T. & Baker, C. W., Mar 2019, In : JAMA Ophthalmology. 137, 3, p. 281-287 7 p.

    Research output: Contribution to journal › Article

    Macular Edema
    Veins
    Retinal Vein Occlusion
    Visual Acuity
    Therapeutics

    Month 24 Outcomes after Treatment Initiation with Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal or Hemiretinal Vein Occlusion: SCORE2 Report 10: A Secondary Analysis of the SCORE2 Randomized Clinical Trial

    Scott, I. U., Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A. & Chan, C. K., Dec 2019, In : JAMA Ophthalmology. 137, 12, p. 1389-1398 10 p.

    Research output: Contribution to journal › Article

    Macular Edema
    Vascular Endothelial Growth Factor A
    Veins
    Randomized Controlled Trials
    Visual Acuity